Listed

Protalix BioTherapeutics, Inc.

PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31

Reports and events: 399 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Protalix BioTherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2015-02-0207:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-005162
2015-01-0807:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-001279
2015-01-0507:06 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-000265
2014-11-1207:31 ET8-K5.07 Shareholder vote results0001144204-14-066830
2014-11-1016:32 ET10-QQuarterly reportPeriod 2014-09-300001144204-14-066530
2014-10-0916:30 ETDEF 14AProxy statementPeriod 2014-11-100001144204-14-060401
2014-09-2916:30 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-14-058399
2014-09-1713:34 ETSC 13D/AOwnership report, active investor, amended0001178913-14-002958
2014-08-2906:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-14-053151
2014-08-2810:21 ETSC 13D/AOwnership report, active investor, amended0001178913-14-002789
2014-08-0716:30 ET10-QQuarterly reportPeriod 2014-06-300001144204-14-047741
2014-07-2416:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-14-044715
2014-06-2707:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-14-039944
2014-06-1807:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-14-038202
2014-06-1308:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-14-037449
2014-05-3007:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-14-034381
2014-05-2207:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-14-032962
2014-05-0816:31 ET10-QQuarterly reportPeriod 2014-03-310001144204-14-028653
2014-03-1316:32 ET10-KAnnual reportPeriod 2013-12-310001144204-14-015468
2014-02-1207:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-14-007755
2014-01-1307:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-14-001804
2013-11-1206:10 ET8-K5.07 Shareholder vote results0001144204-13-060136
2013-11-0716:43 ET10-QQuarterly reportPeriod 2013-09-300001144204-13-059668
2013-10-1506:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-055039
2013-09-2019:04 ETDEF 14AProxy statementPeriod 2013-11-070001144204-13-051645
2013-09-1817:22 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-051455
2013-09-1116:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-13-050235
2013-09-0316:30 ET8-K5.02 Departure or appointment of officers or directors0001144204-13-048995
2013-08-0816:31 ET10-QQuarterly reportPeriod 2013-06-300001144204-13-043990
2013-06-2015:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-13-035824
2013-06-1906:02 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-035540
2013-06-1207:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-13-034416
2013-05-0917:15 ET10-QQuarterly reportPeriod 2013-03-310001144204-13-027499
2013-04-2907:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-024427
2013-04-0207:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-019478
2013-03-1815:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-015768
2013-03-0709:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-013432
2013-02-2816:32 ET10-KAnnual reportPeriod 2012-12-310001144204-13-012065
2013-02-1307:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-13-007983
2013-02-0516:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-13-006107
2012-12-1006:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-067055
2012-12-0607:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-066660
2012-11-0716:06 ET10-QQuarterly reportPeriod 2012-09-300001144204-12-060041
2012-11-0112:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-058841
2012-09-2706:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-053080
2012-08-1307:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-044622
2012-08-0907:33 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-12-043820
2012-08-0317:23 ET10-QQuarterly reportPeriod 2012-06-300001144204-12-042862
2012-07-1816:51 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001144204-12-040015
2012-07-0207:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-037523

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.